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MEDICAL MICROBIOLOGICAL ANALYSIS
OF APOLLO-SOYUZ TEST PROJECT CREWMEMBERS
By Gerald R. Taylor and S N. Zaloguev*
Lyndon B Johnson Space Center
SUMMARY
i
The purpose of the Microbial Exchange Experiment (AR-002) of the Apollo-
Soyuz Test Project was to evaluate components of the infectious disease process
in space flight by measuring alterations in three factors; (1) the composition
of the microbial populations inhabiting the crewmembers and spacecraft, (2) the
ability of each crewmember's defense mechanism to resist infection, and (3) the
ability of certain microorganisms to originate infections, The impetus for per--
forming the experiment arose from the variety of in--flight and ground-based,
microbial studies in the United States and the U.S.S.R.,  which have indicated
that the conditions of space flight alter man and microorganisms in such a way
that the normal fine balance between them may be adversely affected. The moni-
toring of two separate crews, which differed microbiologically and immunolog-
ically, provided an opportunity to study in-flight cross-contamination patterns.
Because the Apollo-Soyuz Test Project crewmembers came from widely different
geographical and ecological areas, it was possible to identify specific, naturally
occurring, marker microorganisms for detailed analysis.
This report evaluates the operational aspects associated with the experiment
and the activities of medically important microorganisms recovered from the
Apollo and Soyuz crewmen. The majority of activities were performed as planned,
and_a large percentage of the anticipated data will be forthcoming. A variety of
potential pathogens was recovered from prime and backup crewmembers before
, 	 and after flight. However, no disease events were reported. Candida albicans
and Staphylococcus aureus- (type 52, 52A, 80, 81) were shownto be rt ars— e£erred
from one crewmember to another during the flight. No other medically significant
changes in the microbial population were observed.
INTRODUCTION
On early Apollo missions, before strict protective measures were instituted,
in-flight infections were not unusual (ref. 1) . In-flight illness of microbial origin
was, however, completely absent from the Apollo 14 through 17 missions (ref. 2) .
*Institute of Biomedical Problems, U.S.S.R. Ministry of Health, Moscow,
U.S.S.R.
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There is no doubt that the implementation of extensive preventive measures
(ref, 3) following the clinically significant Apollo 13 mission was a contributing
factor. Preflight monitoring of pathogenic and potentially pathogenic species
identified certain potential problems so that appropriate prophylaxis or treatment
could be administered before the flight or could be provided during the flight.
This procedure was highly effective and was recommended for all future U.S,
manned space flights (ref. 2) Similar analyses conducted during th% three
flights to the U.S.  Skylab demonstrated that, whereas there were several in-flight
disease events and gross contamination of the orbital workshop did occur, such
events were not shown to be limiting hazards for long-term space flight (ref. 4) .
The results of microbiological studies conducted as part of ground-based
experiments in the U.S.S.R.  and during the flights of Soyuz spacecraft (ref. 5)
indicate that the state of human beings in hermetically sealed cabins can be ,assn-
ciated with certain shifts in the composition of their automicroflora. It has been
reported (refs. 6 and 7) that these changes were of a dysbacteriological character
and were expressed as a marked increase in the size of the microbial population
in different areas of the integument. Such increases may be due to a predom-
inance of individual representatives of the autoflora, such as staphylococci,
streptococci, or Gram-negative rods of the genus Escherichia or Kle bsiella. This
predominance could be an important factor in theeve opment of t e symptom-
atology of infections, Increased intensity of shedding of microorganisms from
the skin of crewmembers into the cabin environment (refs. 6 and 7) favors the
creation of conditions suitable for the exchange of microorganisms between.
individuals
The Apollo-Soyuz Test Project (ASTP), a unique space flight in which two
teams of crewmembers from different geographical areas joined in space with two
different spacecraft, presented an unusual opportunity for cross-contamination.
Accordingly, it was necessary to identify and trace the presence of all micro-
organisms of potential medical importance. This report covers such an analysis
of the three prime and three backup Apollo astronauts and the two flight and two
backup Soyuz cosmonauts
As an aid to the reader, where necessary the original units of measure have
been converted to the equivalent value in the Systeme International d'Unites (SI) .
The SI units are written first, and the original units are written parenthetically
thereafter.
METHODS AND MATERIALS
Routine Method
Nine sets of microbiological specimens were collected from the three prime
Apollo crewmembers (43, 29, 18, 5, and -0 days before launch; once during flight;
and 0, 18, and 29 days after recovery) . Additionally, six sets of control speci-
mens were collected from the three backup Apollo crewmembers (45, 32, 18, 5,
and 0 days before the flight and immediately after the flight) . Nine sets of micro-
biological specimens were taken from the two prime Soyuz crewmembers (48, 33,
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15, 7, and 0 days before launch; once during flight; and 0, 7, and 15 clays after
recovery) . In addition, four sets of microbiological samples were collected from
the two backup Soyuz crewmembers (45, 29, 14, and 6 days before the flight).
During each preflight and postflight sample period, 10 microbial specimens
were collected from each crewmember as outlined in table I. Calcium alginate
swabs, wetted in 0.3-millimolar phosphate buffer, were used to sample each of
the seven body surface areas. Although it is recognized that subsurface microbes
may be overlooked by this method, procedures f,-r, sampling subsurface areas
were not compatible with the flight program (refs. 2 and 8) . Dry calcium alginate
swabs were used to sample the surfaces of the tonsils and the posterior pharyngeal
vault before collection of the gargle specimen. For this latter sample, the subject
gargled with 0.3-millimolar phosphate buffer followed by a repeated rinse of the
teeth with the same solution Swabs were placed in 5 cubic centimeters of
0.3-millimolar phosphate buffer for transport to the laboratory. Analysis of all
samples was initiated within 1 hour of specimen collection.
In-Flight Microbial Specimen Collection
In addition to the baseline samples previously described, in-flight samples
were obtained from all five prime crewmembers and both spacecraft between 77: 40
and 78: 30 Soyuz E i •ound elapsed time. In--flight samples consisted of the first six
areas outlined in table 1. For this set of samples a specially developed sample
collection device was employed (fig. 1), This device consisted of a cotton - tipped
Teflon swab on a capillary tube that contained conservation fluid to keep the micro-
organisms alive. Each swab was housed within an airtight case to prevent desic-
cation. Groups of swabs were organized in Beta-cloth retaining bags (fig. 2)
Preliminary Analysis of Microbial Specimens
The contents of each swab and gargle sample were serially diluted under
aseptic conditions and subsequently inoculated onto the surface of the nutrient
media (table 11). The variety of media, number of plates inoculated, and dilution
range were selected on the basis of what was required to isolate and quantitate the
autoflora components present in each sampled area (ref. 9), Sabouraud's dex-
trose agar (SAB) plates were incubated at 303 K (30° C) for 5 days. Cornmeal,
malt-extract yeast-extract agar (CMMY) plates were incubated at 298 K (25° C)
for 7 days, and all others were incubated at 310 K (37° C) for 48 hours.
Following incubation under the appropriate conditions, all resulting colonies
on every culture plate were categorized and counted. Subsequently, one sample
of each morphologically different colony type was transferred from each dilution
series to the appropriate nutrient media and was stained according to the method
of Gram. - Species were identified as previously outlined (refs. 9 and 10)
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RESULTS AND DISCUSSION
Medical microbiological analyses of Apollo crewmembers were conducted at the
NASA Lyndon B. Johnson Space Center laboratories in Houston, Te tas, and eval-
uations of specimens from Soyuz crewmembers were conducted at the Institute of
Biomedical Problems of the U.S.S.R.  Ministry of Health in Mose-w. Although
these studies were conducted individually, a common methodol^ ,y was used to
ensure comparability of data. In addition, nutrient and selective culture media
were exchanged so that these variables could be reduced. The following rep-
resents the analyses of medically important microorganisms contributed by each
side,
Gram-Negative hods Isolated From Apollo Astronauts
Enteric microorganisms.- A number of different microbes that normally occur
in the intestinal tract, or are associated with intestinal infection, are placed in the
enteric group of bacilli. The normally occurring members of this group are gen-
erally considered to be of potential medical importance when they are recovere6
repeatedly, or in large numbers, from sites other than the lower digestive trv.vt,
The following members of this group were recovered from areas on the AST*``'
crewmembers other than the lower digestive tract. An outline of the total recovery
pattern for the Apollo crewmembers is presented in tables III to VI
Escherichia coli: Escherichia coli is generally accepted as the most reliable
evidenced fecal contamination, Outside the intestinal tract, under certain con-
ditions, it often produces such diseases as urinary tract infections (cystitis and
pyelitis), peritonitis, gallbladder infection, wound infection, septicemia, and
enteritis. This species was repeatedly recovered from the groin of the prime
Apollo command module pilot (CMP) and occasionally from the upper respiratory,
tract of the other two prime Apollo crewmembers. In all cases, neither the re-
covery pattern nor the quantitation indicated medical significance.
Enterobacter aerogenes Enterobacter aerogenes often occurs in the large
intestine of
	
although the number present is considerably smaller than
that of E. coli. The pathogenic significance of E. aero enes is similar to that of
E. coli. As indicated in tables III and IV, this species was always carried in the
nose and mouth of the prime Apollo CMP and docking module pilot (DMP) and was
frequently isolated from the backup Apollo commander (CDR) and DMP . Although
this is not a common occurrence, it should be noted that this species was not shown
to spread to the prime Apollo CDR or to more sites on the carriers during the flight.
Also, there was no postflight increase in quantitation . This occurrence is an
excellent example of a potential pathogen, carried by two flight crewmembers,
apparently being unaffected by the conditions of space flight.
Proteus mirabilis: Members of the genus Proteus may cause infections of the
urinary tract and abscesses. Additionally, these microbes have been associated
with outbreaks of enteric infection, particularly gastroenteritis. More often, they
are secondary invaders of infections of the middle ear, mastoid process meninges,
wounds, and urinary tract. P. mirabilis is the most frequent species of this genus
found in human clinical material. This species was carried, in low numbers, in
4
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the nasal passage of the prime Apollo GDR throughout the monitoring period, As
with I, aerogenes previously described, this unusual event provides a good model
system for analyzing the response of Gram-negative rods to space-flight condi-
tions. The ASTP mission had no detectable effect on the qualitative or quantitative
presence of this microorganism
Other Gram-negative rods. - Nonenteric Gram-negative rods discussed in this
section include members of the genus Moraxella, Acinetobacter calcoaceticus, and
four species of Haemophilus.
Moraxella species: Members of the genus Moraxella are parasites of the
mucous membranes and are frequently involved in pathogenic activity such as con-junctivitis, Although carried in the oral cavity of the prime Apollo DMP for 45 daysa	 before the flight, no discernible alteration was demonstrated following the mission.
Acinetobacter
 calcoaceticus; Acinetobacter ca lcoaceticus (synonym; Mima
pot moor h_a_) is a specie o mf i potent^med
 medical importance. Isolated infre=
quentl r m multiple sites on the prime 4pollo CMP, it did not contribute signifi-
cantly to the load of Gram-negative rods recovered from ASTP prime crewmembert',
Haemophilus; Four species of Haemophilus were isolated from the oral cavity
of each ASTP Apollo astronaut as outlined in tables V and VI. Although each of
these is to some degree a common inhabitant of the human mouth, each is a strict
parasite requiring certain growth factors present in blood. A discus. Un of the
potential medical importance of each follows,
H. influenzae is found in lesions and in the upper respiratory tract of carriers.
It may be eitherer a primary or a secondary invader, As a primary incitant of
disease, it is responsible for meningitis, septicemia, conjunctivitis, and upper
respiratory tract infections. It is commonly a secondary invader in cases of
influenza and pertussis This species was isolated from each of the Apollo crew-
members before flight in quantitations ranging from 10 000 to 600 000 viable cells/
cm  of gargle. The postflight loss from two Apollo crewmembers and th e quanti-
tative reduction in contamination of the Apollo CDR is eontraindicative of a space-
flight-mediated increase in infective potential.
H. haemolyticus and H, parahaemolyticus are often associated with acute phar-
°	 yngitis when present in high numbers As with the H. influenzae, the overall
quantitation and incidence decreased following the ASTP flight.
H. parainfluenzae is the most benign of the four recovered species and is used
largely as a marker organism because of its almost ubiquitous appearance.
Gram-Negative Rods Isolated From Soyuz Cosmonauts
The results of the studies of the content of Gram-negative rods on the skin of
the cosmonauts of the prime Soyuz crew (table VIII revealed a postflight increase
in the quantity of Acinetobacter calcoaceticus and an increase in the frequency of
occurrence of microorganisms of the family Enterobacteriaceae. Data for the
recovery of Gram-negative rods from the Soyuz backup crewmembers are given in
i	 5
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table VIII, Considering the medical importance of the bacteria of this family, the
increase in the number of skin areas from which the mentioned microbes were
Isolated should be considered as unfavorable.
Candida Albicans
Candida albicans is a well-recognized component of the indigenous autonora
of humans(ref . 11) and has been recovered from astronaut specimens collected in
association with each Apollo And Skylab mission (refs. 2, 4, and 8) . Because C.
albicans has been identified as the causative agent for serious oral cavity diseases(re s . 11 and 12) , the presence of this microorganism in the mouths of ASTP crew-
members was carefully monitored. As previously reported (ref. 10), C. albicans
was recovered from crewmembers following the Apollo 14 and 15 missions,
whereas other fungal species, present before flight, were absent from samples
obtained immediately after recovery. Analysis of the ASTP Apollo astronaut data
prese^:ted in table IX indicates an in-flight transfer of this species to the Apollo
CDR. No such transfer occurred with the Apollo backup crew, although C.
albicans was carried in the mouth of the backup CMP . These events demonstrate
the importance of this species in space flight. In-flight use of antibiotics could
provide the opportunity for a loss of competing bacterial sp+,bcies and eventual
overgrowth with C, albicans, thereby increasing the importance of this yeast
(refs 12 to 14) .
Among the Soyuz cosmonauts, C. albicans was recovered only from the prime
flight engineer (FE) 33 and 15 days before launch. Therefore, this microorganism
was not considered to be of medical importance for the Soyuz crewmembers.
Staphvlococcus Aureus
Although Staphylococcus aureus is not an uncommon skin and nasal contami-
nant, it is an important potential pathogen. It has been shown to be the causative
agent of a wide range of infection and intoxications including boils, abscesses,
meningitis, furunculosis; pyemia, osteomyelitis, suppuration of wounds, and
food poisoning (ref, 15). Several space-flight-simulation studies (refs. 6, 7,
and 16) have indicated increases in the toxigenic activity, virulence, or patho-
genicity of this species with stressful confinement of the human host. If these
events were to be duplicated during space flight, the resulting lesions could be
especially important because of their interference with close-contact surfaces,
such as the tight.-fitting and abrasive pressure suits, oxygen masks, and other
components of the life support system. Accordingly, the presence ands.ctivit y of
this species were monitored before and after each of the recent U.S,  space '':.ghts ,
Data from the Apollo 13, 14, and 15 missions (ref. 2) and from the Skylab missions
(ref, 4) confirm in-flight cross-contamination with S. aureus
The recovery of this species from ASTP Apollo crewmembers in connQ ,tion with
previous space flights is presented in table X. The ASTP prime DMP had ,lot pre-
viously been assigned to a space flight, rendering such data nonapplicable.
Strains of S. aureus were recovered from all the other five ASTP astronauts in
connection—with at least one previous space flight.
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The recovery of strains of S. aureus fr rfl!i the Apollo astronauts during the
ASTP monitoring period is presented`Intable XI, These strains are expressed as
numbered bacteriophage types. The data show that each Apollo prime and backup
crewmember carried a different strain of S. aureus, Type 52, 52A, 80, 81 was
carried by the prime DMP and was transferred to t e prime Apollo CDR during
flight, Apparently, colonization did not ensue because this strain was not
recovered again from the prime Apollo CDR,
A postflight increase in the incidence of S. aureus isolation has previously
been reported (refs. 2 and 4) . This increase did not occur among the astronauts
after the ASTP mission, Likewise, and contrary to some previous missions
(ref. 4), no disease events resulted from the ubiquitous presence of S aureus
before and during the flight.
Total Load of Potential Pathogens
Several investigators have suggested that returning space travelers may
experience a "microbial shock" and respond negatively to ,renewed contact with
potentially pathogenic microorganisms that are absent in the space-flight environ-
ment (refs. 1, 17, 18, and 19). These warnings were based on the assumption
that contact with potential pathogens during space flight would be very limited,
resulting in a reduction of immunocompetence. However, there was no demon-
strable decrease in the incidence of medically important microorganisms recovered
from the ASTP crewmembers on recovery day. This finding supports results
reported earlier (refs, 2, 5, and 9) . Therefore, if a reduction in total immuno-
competence were to occur during this mission, it could not be in response to
decreased contact with medically important components of the resident microflora ,
CONCLUDING REMARKS
This medical/ microbiological analysis of the Apollo-Soyuz Test Project crew-
members was conducted as part of the Microbial Exchange Experiment (AR-002).
Although a variety of potential pathogens was recovered from each of the prime
and backup crewmembers before and after flight, no disease events were reported.
Candida albicans and Staphylococcus aureus (type 52, 52A, 80, 81) were shown to
be transferred from one crewmember to another during flight. No other medically
significant changes in the microbial population were observed
Lyndon B Johnson Space Center
National Aeronautics and Space Administration
Houston, Texas, April 8, 1976
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TABLE I.- SAMPLE COLLECTION AREAS
Sample
no,
Sample
designation
Sample area
1 Hair 20-cm2 area of hair (and scalp) on top of head
2 Ears Right and left external auditory canals with 2
revolutions of each swab in each ear canal
3 Neck 20-cm 2 area below hairline at base of neck
4 Nose Internal area of both nostrils
5 Throat sw--b Surfaces of tonsils and posterior pharyngeal
vault
6 Hands 20-cm2 area on right and left palms
7 Axilla 20-cm2 area below hair on each side
8 Groin 5-cm strip from rear to front on right and left
inguinai area between legs
9 Toes Area between the two smallest toes of each foot
10 Gargle 10 cm  of phosphate buffer used as gargle and
washed through oral cavity 3 times
1I
i
t
7
I
TABLE II.- ISOLATION MEDIA
Sample designation Media Number of Dilution range
plates
Back of neck Blood agar 2 a101 to 101
Hair Mannitol salts agar 3 100 to 101
Hands Cornmeal, malt-extract, yeast- 4 109
Axilla extract agar (CMMY)
Ears Sabouraud's dextrose agar (SAB) 5 100
Gargle (natural) Blood agar 2 100 to 101
Mannitol salts agar 3 100 to 101
CMMY 4 101 to 101
Rogosa agar 3 100 to 191
Chocolate bacitracin agar (Choc) 3 100 to 101
Gargle CMMY 4 101
(centrifugate) SAB 5 101
Nose Blood agar 2 101 to 101
Mannitol salts agar 3 101 to 101
CMMY 4 10°
SAB 5 10°
Choc 3 101 to 101
Toes and groin Blood agar 2 100 to 101
Mannitol salts agar 3 101 to 101
CMMY 4 10°
SAB 5 10°
Throat swab Blood agar 2 101 to 101
Mannitol salts agar 3 100 to 101
CMMY 4 101 to 101
SAB 5 10°
Choc 3 100 to 101
Rogosa agar 3 10° to 101
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TABLE V,- RECOVERY OF GRAM-NEGATIVE RODS FROM ASTP APOLLO PRIME
CREWMEMHERS (GENUS HAEMOPHILUS)
Crew-
member
Species of
Heemophilus
Quantity of bacteria. log j# colony-forming units/em l of gargle or swab diluent
Days before flight Days after flight
F-43 F-29 I	 F-18 F-5 F-0 R+0 R+18 R+29
Throat swab
ACDR 11, haemolyticus 0 0 4.47 0 0 0 0 0
If. influenzae 0 0 4.90 0 0 3,34 0 0
H. parahaemolyticus 0 0 0 0 0 0 0 0
H. parainfluenzae 4,50 5,04 5,36 5,17 5,20 3,49 4,62 2,18
Chi p H, haemolyticus 5,60 5,47 0 0 0 3.30 0 0
N, influenzae 5,77 0 0 0 0 0 0 0
H. parahaemolyticus 0 0 4.00 5,90 0 0 0 0
H. parainfluenzae 5,69 6.04 5.14 5190 5,36 3,84 5.87 5,49
DMP H. haemolyticus 0 0 4,47 0 0 0 0 0
H. influenzae 0 0 0 0 4.00 0 0 0
H. parahaemoly',b lus 0 0 0 0 0 0 5.11 0
H, parainfluenzae 5,41 5,23 '4,84 6,46 5,45 4.77 4,90 4.00
Gargle
ACDR H, haemolyticus 0 0 6.49 0 0 5.30 0 0
H. influenzae 0 4.90 5.77 0 0 0 0 1,48,
H, parahaemolyticus 0 0 0 0 0 5.00 0 0
H. parainfluenzae 5.54 5,99 6,77 6,53 6.53 5.95 5,08 4.18
CMP H, haemolyticus 0 6,30 0 6,90 0 0 0 0
H, influenzae 5,69 0 0 0 0 0 0 0
H, parahaemolyticus 0 0 6,30 7.11 0 0 0 0
H. parainfluenzae 6,23 7.08 7.20 7,39 6.48 5.15 6.48 7.00
DMP H. haemolyticus 0 0 5.77 0 0 0 5.78 0
H. influenzae 0 0 0 0 0 0 0 0
H. parahaemolyticus 4,69 0 0 5,30 0 5.30 5100 0
H. parainfluenzae 5,44 6.04 6.43 6.80 6,28 5,52 6.25 5.46
yj
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TABLE VI', RECOVERY OF GRAM-NEGATIVE RODS FROM ASTI' APOLLO BACKUP
CREWMEM©ERS (GENUS IIAEMOPIIILUS)
Crew- Species of quantity of bacteria, log,i colony-forming units/cm'
member Ilaem22hilus
of gargle or swab diluent
Days before flight Day of recovery
F-45 F-32 F-18 F-5 F-0
Throat swab
ACDR H, haemolyticus 0 4,60 0 0 0 0
H, influenzae 0 0 0 0 0 0
H, parahaemolyticus 4.30 0 4,11 0 0 0
!I, parainnuenzae 5.32 4,95 7,95 5.81 6.05 5.38
CHIP H. haemolyticus 0 0
_0
0 0 0
Ii. innuenzae 0 0 0 0 0 0
if. parahaemolyticus 0 0 4.65 4,65 4,57 0
H. parainfluenzae 4.34 2.30 3.95 3,60 4,48 4.57
DMP H. haemolyticus 0 0 0 5,04 0 0
Ii. influenzae 0 4.00 0 3,00 3.00 0
Ii. parahaemolyticus 0 0 0 0 0 0
H. parainnuenzae 2.44 5.20 4.41 4,69 4.04 4.15
Gargle
ACDR H. haemolyticus 5.47 0 0 0 0 5,00
H. innuenzae 0 0 0 0 0 0
H. parahaemolyticus 0 0-- 0 0 0 0
H, parainfluenzae 5.95 6.54 6,60 0 6.49 6.36
CMP H. haemolyticus 0, 0 0 0 0 0
H. innuenzae 0 0 0 0 0 0
II, parahaemolyticus 0 0 6100 6.77 0 5.30
lf. parainfluenzae 4.70 0 6,43 6,36 5,86 6.41
DMP H. haemolyticus 0 0 0 0 0 0
!i. influenzae 3.00 0 0 0 0 0
H. parahaemolyticus 4.25 0 0 0 4,00 4.30
Fl. parainfluenzae 0 6,73 7.43 7,43 5.81 5.00
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TABLE X.- STAPHYLOCOCCUS AUREUS RECOVERY FOR ASTP APGLLG
CREWMEMRERS PROM PREVIOUS SPACE FLIGHTS
Crowmembor Flight Sampling period! $Ample AM Phalle type
Prime ASTP crew
ACOR Apollo 10 F•30 Hands NAB
CMP Apollo 15 F-30	
_
Scalp NTb
Nose 06
P-6 Nose 05
Mouth NT
Skylab 3 P-30 Groin NT
Nose 75/65
F-14 Groin NT
F 5 Mouth 76/85
Nose NT
Skylab 4 F-30 Groin N3,
Nose 75/65
F-14 Nose, groin NT
Mouth 75/85
F'°5 Fur, groin NT
None 29/75
Mouth, scalp 29/47/75
DMP Clinic Mouth 03-A
Backup ASTP Crew
ACDR Apollo 12 F-30 Scalp, ears, sxillo, NA
hands, none, inguinal
r-14 Nose NA
F-0 Toes, nose NA
-R+0 Nose NA
Skylab 3 F-45 Nose, mouth 3-A
F -14 Scalp, navel, nose, 3-A
groin
F-5 Nose 3,A
F-0 Nose 3-A
R+O Hands 3-A
Nose 3-A/3-C
R+8 Nose, hands, navel 3-A
Groin 3-A/ 3-C
11+15 Scalp 3-A/3-C
Nose, axilla, hands 3-A
Navel 3-C
CMP Apollo 14 F-14 Nose, hands 6/47/53154/77/
'9/80/81
DMP Skylab 3 F-45 Scalp 29179
Groin 29/ 79/ rW
Nose 29/52,-4,,:'79/80
F-14 Nose 29/53/54/79/80
F-$ Bands 29/79
Noce NT
R+0 Mouth, scalp, feces 29/79
Hands 3-A
Nose 29/53/54/79/80
R+8 Mouth 29153179/80
11+18 Nose 29/79
Mouth 29/53/79/60
Not applicable (typing not done).
bNontypable,
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(vj jOpen kit showing- sample collection devices in place.
Figure 2 Beta-cloth sample collection kit used for crewmember samples
in the Apollo spacecraft,
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